安进实验性减肥药临床试验结果公布 股价跌幅达7%
news flash·2025-06-23 18:59
Group 1 - Amgen's stock has dropped by 7% following the release of clinical trial results for its experimental weight loss drug [1]
Group 1 - Amgen's stock has dropped by 7% following the release of clinical trial results for its experimental weight loss drug [1]